Sorry, you need to enable JavaScript to visit this website.

CYTARABINE - FOR INTRAVENOUS OR SUBCUTANEOUS USE ONLY (cytarabine injection) Indications and Usage

INDICATIONS AND USAGE

Cytarabine in combination with other approved anticancer drugs is indicated for remission induction in acute non-lymphocytic leukemia of adults and children. It has also been found useful in the treatment of acute lymphocytic leukemia and the blast phase of chronic myelocytic leukemia.

Intrathecal administration of cytarabine injection (preservative-free only) is indicated for the prophylaxis and treatment of meningeal leukemia.

What's New

No Current Announcements.

Contact Pfizer Medical

Search

Please enter your search term(s) for CYTARABINE, 500 MG/25 ML MULTI-DOSE VIAL U.S. PHYSICIAN PRESCRIBING INFORMATION